Author: VcanBio USA-CTB

VcanBio’s Scientific Advisor Dr.Lieping Chen Awarded Warren Alpert Foundation Prize

No Comments

June 6, 2017    By Linc Ma

The Warren Alpert Foundation, in association with Harvard Medical School, announced that Dr. Lieping Chen will be one of five 2017 award recipients. The award honors scientists who pioneered the transformative discoveries in the field of cancer immunology.

“The award is a great honor and a wonderful recognition of our work.”—–Dr. Lieping Chen

Dr. Chen is the United Technologies Corporation Professor in Cancer Research and professor of immunobiology, of dermatology and of medicine at Yale University. He has been the scientific advisor of VcanBio since 2016.

Learn more from Harvard Medical School and Warren Alpert Foundation.

China’s biotech Vcanbio launches US subsidiaries

September 22, 2016    By The Pharma Letter

Vcanbio Cell & Gene Engineering Corp (SSE: 600645), which claims to be China’s largest biotechnology company, has expanded its horizon by opening an office in the USA.

Vcanbio USA and Vcanbio Center for Translational Biotechnology (VCANBIO CTB) have hosted an opening ceremony to celebrate the launch of US operations as subsidiaries of the parent firm, a company focused on cell therapy and precision medicine, both located in Natick, Massachusetts…….Read full article from The Pharma Letter

Chinese biotech Vcanbio opens first U.S. subsidiaries in Natick

September 13, 2016    By Boston Business Journal

A company that touts itself as the largest Chinese biotech company, called Vcanbio, has chosen Natick as the site of its first U.S. operations.

This past weekend, the Vcanbio Cell & Engineering Corp. opened a 15,504 square foot office and lab space at 21 Strathmore Road, the same building that formerly housed stem cell biotech Parcell Laboratories. There, Vcanbio has 20 employees and says it has plans to grow……Read full article from Boston Business Journal

Chinese biotech opens U.S. subsidiaries in Natick

September 13, 2016    By Worcester Business Journal

What is touted as the largest Chinese biotech company opened the doors of its first U.S. subsidiaries over the weekend in Natick as company officials seek to enter the U.S. market.

The location at 21 Strathmore Road will house the corporate offices and laboratories for VCANBIO USA and VCANBIO Center for Translational Biotechnology. These entities represent the launching of U.S. operations for parent company VCANBIO Cell & Engineering Corporation Ltd., which is focused on cell therapy and precision medicine, according to a release. The ribbon cutting for the U.S. location took place Saturday……Read full article from Worcester Business Journal

China’s Vcanbio unveils U.S. subsidiaries in Massachusetts

September 10, 2016    By Xinhua News Agency

NEW YORK, Sept. 10 (Xinhua) — China’s Vcanbio Cell & Gene Engineering Corporation, Ltd. on Saturday formally announced the operation of its two branches in the United States, marking the establishment of its North America headquarters.

The company’s two subsidiaries, Vcanbio USA Co. Ltd. and Vcanbio Center for Translational Biotechnology (CTB), are both located in Natick, in the northeastern U.S. state of Massachusetts……Read full article from Xinhua New Agency